Our editorial approach
We gather evidence from primary sources, peer-reviewed literature, official registries, and on-the-record media. Where public safety or clinical claims are involved we cross-check reporting against authoritative sources such as the National Institutes of Health; for broad methodological context we reference standards used in research synthesis, including established summaries available on systematic review methodology and regulatory guidance.
Our editorial review prioritizes traceable citations and clarity about uncertainty. When reporting on cost or availability we link to operational resources that track treatment markets; for example, we direct readers to regional treatment listings like those maintained by independent directories and review sites, such as the Utah-focused site that lists regional service options at ibogaine treatment listings in Utah.
How we vet sources
We prefer primary clinical studies, official health agency statements, and direct interviews over hearsay. For background on clinical evidence hierarchies we consult public-facing summaries from recognized institutions; for example some methodological context is available through university-hosted resources and official health libraries like the U.S. National Library of Medicine at NLM.
Editorial principles
- Independence — No affiliation with treatment providers; clear disclosure of any potential conflicts.
- Evidence before claims — Prioritise documented, verifiable sources.
- Plain language — Explain methods and limitations in accessible terms.
- Cultural respect — Contextualize narratives without appropriation or sensationalism.
What we cover
Gentle Clearing 95 curates explanatory pieces, timelines, and annotated media analyses that connect public narratives to documentation. The site organizes content into thematic sections (context and definitions, ethical considerations, and an evolving media timeline) and provides focused resources on service access and cost studies; for example, when readers ask about comparative treatment pricing we reference dedicated cost-aggregation resources such as cost of ibogaine treatment summaries to illustrate how pricing data is collected and reported.
Who this is for
The audience includes researchers, journalists, clinicians seeking cultural context, and members of the public who want evidence-oriented summaries rather than promotional material. If you are exploring treatment options, we suggest consulting licensed professionals and official clinical registries rather than relying on this site for personalized advice; directories and detox center listings we reference—such as independent directories that track detox providers—are illustrative only, for example see ibogaine detox center listings.
For practical inquiries about treatment modalities and how they are represented in popular culture, readers sometimes explore practitioner or market-focused pages such as treatment-withdrawal comparisons and methadone interactions documented on specialist pages like ibogaine and methadone interactions.